Related Experiment Video
Updated: Aug 6, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation
Limin Wijaya1, Li-Yang Hsu, Asok Kurup
1Department of Internal Medicine, Singapore General Hospital, Singapore.
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a growing global threat, causing distinct infections. Local strategies are needed to manage increasing CA-MRSA prevalence and prevent widespread epidemics.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is emerging globally.
- CA-MRSA differs from healthcare-associated MRSA (HA-MRSA) in antibiotic susceptibility and infection types.
- CA-MRSA strains have diverse genetic backgrounds and virulence factors.
Purpose of the Study:
- To describe the geographic distribution of CA-MRSA molecular subtypes.
- To discuss the local implications of CA-MRSA emergence.
Main Methods:
- Literature review of CA-MRSA genetic analyses using Multi-Locus Sequence Typing (MLST).
- Inclusion of Singapore-specific CA-MRSA data from a local database.
Main Results:
- Epidemic CA-MRSA subtypes are present in most regions analyzed.
- Community MRSA infections surpass susceptible strains in some US areas.
- ST30 clone spread drives increasing CA-MRSA infections in Singapore.
Conclusions:
- The rise of community MRSA is persistent, not transient.
- Local guidelines for CA-MRSA treatment and prevention are essential.
- Proactive measures are needed to avert HA-MRSA-like endemicity or US-like CA-MRSA epidemics.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Mismatch Repair
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance